Skip to main content

Table 4 Neonatal outcomes across the study groups

From: Is there a role for oral misoprostol in labor induction for prelabor rupture of membranes at term?

 

Oral Misoprostol (n = 493)

IV Oxytocin (n = 296)

Odds Ratio

95% CI

p-value

Neonatal birthweight

(mean, s.d.grams)

3240 ± 411.9

3277 ± 401

N/A

0.3

Macrosomia (n,%)

20(4%)

12 (4%)

1 (0.5–2.1)

0.5

APGAR < 7 at 5 min (n,%)

1 (0.2%)

0

N/A

N/A

Umbilical artery pH < 7.1 (n,%)

1 (0.2%)

1 (0.31%)

0.6 (0.03–9.2)

0.4

NICU Admission (n,%)

0

0

N/A

N/A

Respiratory Morbidity (n,%)

4 (0.81%)

4 (1.4%)

0.6 (0.1–2.4)

0.2

Sepsis (n,%)

0

0

N/A

N/A

Early-onset GBS disease (n,%)

0

0

N/A

N/A

Hypoglycemia (n,%)

0

1 (0.31%)

N/A

N/A

Jaundice (n,%)

0

1 (0.31%)

N/A

N/A

Necrotizing enterocolitis (n,%)

0

0

N/A

N/A

Composite neonatal outcome (n,%)

6 (1.2%)

7 (2.3%)

0.9 (0.2–3.1)

0.4

  1. IV – Intravenous, s.d. standard deviation, CI – Confidence interval, N/A – Not applicable
  2. NICU - Neonatal Intensive Care Unit, GBS - Group B Streptococcus